<DOC>
	<DOC>NCT00892372</DOC>
	<brief_summary>Control of body weight (BW) is important to prevent and manage type 2 diabetes. Regardless of the close association, little is understood about the precise relationship between BW and glycemic control, which might be of benefit for patients with type 2 diabetes. The researchers investigated the correlation between changes in BW and glycemic control in patients with type 2 diabetes treated with a diet therapy or pioglitazone.</brief_summary>
	<brief_title>Relationship Between Body Weight and Glycohemoglobin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>type 2 diabetes under reasonable glycemic control (HbA1c; less than around 7%) type 2 diabetic patients treated with the diet therapy type 2 diabetic patients with edema, severe liver dysfunction, renal dysfunction, moderate to severe anemia or congestive heart failure type 2 diabetic patients treated with insulin therapy</criteria>
	<gender>All</gender>
	<minimum_age>32 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>body weight</keyword>
	<keyword>glycohemoglobin</keyword>
</DOC>